A stock subscription agreement aimed at a joint investment in アルフェナックス バイオロジクス株式会社 was executed. The announcement was made at 16:43 on 9 November 2026.
This reports the announcement of the execution of a stock subscription agreement based on a joint investment in アルフェナックス バイオロジクス株式会社. The announcement was made at 16:43 on 9 November 2026 and included notification that the agreement had been executed.
The agreement is intended to establish a capital alliance through a joint investment. The text states that it explains the background and purpose of the agreement, but does not include specific figures such as the investment ratios or amounts.